Attention-Deficit/Hyperactivity Disorder
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Human Genetics
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Genome-wide Association Studies-GWAS
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Karen Sheehan1, Ziarih Hawi, Michael Gill
1Neuropsychiatric Genetics, Trinity Centre for Health Sciences, St. James' Hospital, Dublin 8, Ireland. sheehak@tcd.ie
This study investigated the link between Tryptophan Hydroxylase 2 (TPH2) gene variants and Attention Deficit Hyperactivity Disorder (ADHD). The findings did not replicate previous associations, suggesting larger studies are needed to confirm any genetic connection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: